Therapeutic Solutions International Files Patent on Cancer Immune Modulation Using Its ProJuvenol(TM) Product
Marketwired - Thu Jul 09, 7:30AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of its ProJuvenol(TM) product, as well as various pterostilbene compositions, for use in augmenting efficacy of existing immuno-oncology drugs that are currently on the market. The patent is based on the ability of pterostilbene, one of the major ingredients of ProJuvenol(TM), to reduce oxidative stress produced by cancer cells, which in turn protects the immune system from cancer mediated immune suppression.
Therapeutic Solutions Announces Shipping of ProJuvenol(TM) and T-Rx(TM)
Marketwired - Mon May 18, 7:45AM CDT
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the availability of our flagship product ProJuvenol(TM).
Therapeutic Solutions Announces New Product Line and Launch of E-Commerce Platform
Marketwired - Mon May 04, 8:00AM CDT
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the opening of our e-commerce platform for the sales of our specialty line of Nutraceutical products.
Therapeutic Solutions International Updates Shareholders
Marketwired - Tue Feb 03, 8:02AM CST
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) released a shareholder update from its Board of Directors today as follows: